Boston, MA Newmark has promoted capital markets professionals Edward Maher to executive vice chairman and co-head of capital markets and Matthew Pullen to vice chairman of Newmark’s capital markets group–led by co-head of U.S. Capital Markets Robert Griffin, working closely with co-head of U.S. Capital Markets Kevin Shannon.
Maher and Pullen will focus on a strategic office and life science capital markets expansion into East Coast gateway markets, building on best-in-class service for clients across the platform.
“Newmark is committed to recruiting and retaining top real estate investment advisors to support our Capital Markets practice in all key markets,” said Newmark chief revenue officer Lou Alvarado. “Woody and Matt have demonstrated exceptional depth of client relationships, unique sector insight, superlative transaction execution capabilities and have been an integral part of our Capital Markets growth.”
Notable transactions completed by the group in the past two years include the $1.5 billion recapitalization of 401 Park / 201 Brookline in Boston, the $1.2 billion recapitalization of 50 + 60 Binney St. in Cambridge, the $815 million sale of Charles Park in Cambridge and the $710 million recapitalization of The Innovation and Design Building in Boston.
“Woody and Matt are intrinsic members of Newmark’s Boston Capital Markets group, contributing greatly to the group’s success as one of the nation’s most productive institutional investment sales teams,” said Griffin. “Their commitment to, and track record of, achieving exceptional client results is consistent and of considerable value.”
“As investor interest has rapidly pivoted from the traditional multi-tenant, core office segment to the life science sector, our clients have continued to place their trust in us,” said Maher. “I look forward to building upon this momentum throughout the gateway markets across the East Coast.”
“Our team’s fully-integrated model has proven essential for our clients as they balance office and life science needs, including the life science/industrial convergence driven by significant increases in GMP and biomanufacturing demand,” said Pullen. “We are enthusiastic to apply the model in a broader context as we pursue a strategic scaling of our platform.”
Maher and Pullen have closed more than $75 billion and $45 billion in transactions, respectively, during their 35- and 20-year careers, respectively. Recognized among Newmark’s top investment professionals, Maher and Pullen have earned prestigious industry awards—Newmark’s Boston Capital Markets group has won ‘Investment Sale of the Year’ at the Boston Commercial Broker Association Achievement Awards for each of the past six years.
In addition to Griffin, Maher and Pullen, the Boston Capital Markets group consists of 14 additional transaction professionals along with financial analysis, marketing and research professionals.